+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

ElectroCore Inc (ECOR) - Product Pipeline Analysis, 2021 Update

  • ID: 5367379
  • Company Profile
  • June 2021
  • 52 pages
  • GlobalData

FEATURED COMPANIES

  • NeuroNexus Technologies
  • Setpoint Medical Corp
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

ElectroCore Inc (ElectroCore) is a bioelectronic medicine healthcare company. The company is engaged in developing vagus nerve stimulation non-invasively (nVNS) therapy for neurology and rheumatology. It primarily focused on headache such as episodic cluster headache, migraine, and posttraumatic headache; rheumatoid arthritis; sjogren's syndrome; exploring acute trauma; neurodegenerative conditions, and chronic central inflammation. ElectroCore’s also involved in treating gastric motility disorders, anxiety, depression, and widespread chronic pain. ElectroCore is headquartered in Basking Ridge, New Jersey, the US

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ElectroCore Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • NeuroNexus Technologies
  • Setpoint Medical Corp
  • MORE
ElectroCore Inc Company Overview
  • ElectroCore Inc Company Snapshot
  • ElectroCore Inc Pipeline Products and Ongoing Clinical Trials Overview
  • ElectroCore Inc - Pipeline Analysis Overview
  • ElectroCore Inc - Key Facts
  • ElectroCore Inc - Major Products and Services
  • ElectroCore Inc Pipeline Products by Development Stage
  • ElectroCore Inc Ongoing Clinical Trials by Trial Status
ElectroCore Inc Pipeline Products Overview
  • ElectroCore RMS-1100 Resolution Motility System - Post-Operative Ileus
  • ElectroCore RMS-1100 Resolution Motility System - Post-Operative Ileus Product Overview
  • GammaCore - Gastroparesis
  • GammaCore - Gastroparesis Product Overview
  • GammaCore - Gastroparesis Clinical Trial
  • GammaCore - Opioid Use Disorder
  • GammaCore - Opioid Use Disorder Product Overview
  • GammaCore - Opioid Use Disorder Clinical Trial
  • GammaCore - Parkinsonian Gait
  • GammaCore - Parkinsonian Gait Product Overview
  • GammaCore - Post-Traumatic Headache
  • GammaCore - Post-Traumatic Headache Product Overview
  • GammaCore - Post-Traumatic Stress Disorder
  • GammaCore - Post-Traumatic Stress Disorder Product Overview
  • Gammacore - Reactive Airway Disease
  • Gammacore - Reactive Airway Disease Product Overview
  • GammaCore - Rheumatoid Arthritis
  • GammaCore - Rheumatoid Arthritis Product Overview
  • GammaCore - Sjogren’s Syndrome
  • GammaCore - Sjogren’s Syndrome Product Overview
  • GammaCore - Stroke
  • GammaCore - Stroke Product Overview
  • GammaCore - Subarachnoid Hemorrhage
  • GammaCore - Subarachnoid Hemorrhage Product Overview
  • GammaCore - Subarachnoid Hemorrhage Clinical Trial
  • GammaCore - Traumatic Brain Injury
  • GammaCore - Traumatic Brain Injury Product Overview
  • GammaCore - Traumatic Brain Injury Clinical Trial
  • GammaCore - Ulcerative Colitis
  • GammaCore - Ulcerative Colitis Product Overview
  • GammaCore Sapphire - Post-Traumatic Headache
  • GammaCore Sapphire - Post-Traumatic Headache Product Overview
  • GammaCore Sapphire CV
  • GammaCore Sapphire CV Product Overview
  • GammaCore Sapphire CV Clinical Trial
  • Resolve Stimulator and Proximity Electrode
  • Resolve Stimulator and Proximity Electrode Product Overview
ElectroCore Inc - Key Competitors

ElectroCore Inc - Key Employees

ElectroCore Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • ElectroCore Inc, Recent Developments
  • Apr 29, 2021: electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6
  • Mar 11, 2021: electroCore announces fourth quarter and full year 2020 financial results
  • Mar 04, 2021: electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11
  • Mar 03, 2021: electroCore to Participate at Two Upcoming Investor Conferences
  • May 07, 2020: electroCore to Announce First Quarter Ended March 31, 2020 Financial Results on Thursday, May 14
  • Mar 19, 2020: electroCore to Announce Fourth Quarter and Year Ended December 31, 2019 Financial Results on Monday, March 23
  • Jan 27, 2020: ElectroCore announces rebate agreement with Ascent Health Services for gammaCore preferred brand coverage on all express scripts standard national formularies
  • Jan 13, 2020: electroCore provides business update and select financial guidance
  • Dec 27, 2019: electroCore announces board of directors transition
  • Dec 03, 2019: NICE recommends the use of gammaCore for the treatment of Cluster Headache in the NHS
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • ElectroCore Inc Pipeline Products and Ongoing Clinical Trials Overview
  • ElectroCore Inc Pipeline Products by Equipment Type
  • ElectroCore Inc Pipeline Products by Indication
  • ElectroCore Inc Ongoing Clinical Trials by Trial Status
  • ElectroCore Inc, Key Facts
  • ElectroCore Inc, Major Products and Services
  • ElectroCore Inc Number of Pipeline Products by Development Stage
  • ElectroCore Inc Pipeline Products Summary by Development Stage
  • ElectroCore Inc Ongoing Clinical Trials by Trial Status
  • ElectroCore Inc Ongoing Clinical Trials Summary
  • ElectroCore RMS-1100 Resolution Motility System - Post-Operative Ileus - Product Status
  • ElectroCore RMS-1100 Resolution Motility System - Post-Operative Ileus - Product Description
  • GammaCore - Gastroparesis - Product Status
  • GammaCore - Gastroparesis - Product Description
  • GammaCore - Gastroparesis - Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders
  • GammaCore - Opioid Use Disorder - Product Status
  • GammaCore - Opioid Use Disorder - Product Description
  • GammaCore - Opioid Use Disorder - Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders
  • GammaCore - Parkinsonian Gait - Product Status
  • GammaCore - Parkinsonian Gait - Product Description
  • GammaCore - Post-Traumatic Headache - Product Status
  • GammaCore - Post-Traumatic Headache - Product Description
  • GammaCore - Post-Traumatic Stress Disorder - Product Status
  • GammaCore - Post-Traumatic Stress Disorder - Product Description
  • Gammacore - Reactive Airway Disease - Product Status
  • Gammacore - Reactive Airway Disease - Product Description
  • GammaCore - Rheumatoid Arthritis - Product Status
  • GammaCore - Rheumatoid Arthritis - Product Description
  • GammaCore - Sjogren’s Syndrome - Product Status
  • GammaCore - Sjogren’s Syndrome - Product Description
  • GammaCore - Stroke - Product Status
  • GammaCore - Stroke - Product Description
  • GammaCore - Subarachnoid Hemorrhage - Product Status
  • GammaCore - Subarachnoid Hemorrhage - Product Description
  • GammaCore - Subarachnoid Hemorrhage - Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage
  • GammaCore - Traumatic Brain Injury - Product Status
  • GammaCore - Traumatic Brain Injury - Product Description
  • GammaCore - Traumatic Brain Injury - Non-Invasive Vagal Nerve Stimulation in Veterans with Mild Traumatic Brain Injury (mTBI)
  • GammaCore - Ulcerative Colitis - Product Status
  • GammaCore - Ulcerative Colitis - Product Description
  • GammaCore Sapphire - Post-Traumatic Headache - Product Status
  • GammaCore Sapphire - Post-Traumatic Headache - Product Description
  • GammaCore Sapphire CV - Product Status
  • GammaCore Sapphire CV - Product Description
  • GammaCore Sapphire CV - A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIORII)
  • GammaCore Sapphire CV - A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms: SAVIOR
  • Resolve Stimulator and Proximity Electrode - Product Status
  • Resolve Stimulator and Proximity Electrode - Product Description
ElectroCore Inc, Key Employees
  • ElectroCore Inc, Subsidiaries
  • Glossary
List of Figures
  • ElectroCore Inc Pipeline Products by Equipment Type
  • ElectroCore Inc Pipeline Products by Development Stage
  • ElectroCore Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Setpoint Medical Corp
  • Autonomic Technologies Inc
  • NeuroNexus Technologies
  • Axonics Modulation Technologies Inc
Note: Product cover images may vary from those shown
Adroll
adroll